Cancer-associated fibroblast compositions change with breast cancer progression linking S100A4 and PDPN ratios with clinical outcome
G. Friedman, O. Levi-Galibov, E. David, C. Bornstein, A. Giladi, M. Dadiani, A. Mayo, C. Halperin, M. Pevsner-Fischer, H. Lavon-Pashot, R. Nevo, Y. Stein, H. R. Ali, C. Caldas, E. Nili-Gal-Yam, , R. Scherz-Shouval
The paper tracks changes in cancer-associated fibroblast (CAF) subpopulations during breast cancer progression, linking their ratios to clinical outcomes and BRCA mutations.
Nature Cancer · Jun 29, 2020Peer-reviewedCancer Biology